Search by Drug Name or NDC
NDC 42023-0182-01 Argatroban 250 mg/2.5mL Details
Argatroban 250 mg/2.5mL
Argatroban is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is ARGATROBAN.
Product Information
NDC | 42023-0182 |
---|---|
Product ID | 42023-182_cc7c27e1-b4af-463d-a25b-0fbfa260d4b4 |
Associated GPIs | 83337015002020 |
GCN Sequence Number | 047021 |
GCN Sequence Number Description | argatroban VIAL 100 MG/ML INTRAVEN |
HIC3 | M9T |
HIC3 Description | THROMBIN INHIBITORS, SELECTIVE, DIRECT, REVERSIBLE |
GCN | 86464 |
HICL Sequence Number | 021768 |
HICL Sequence Number Description | ARGATROBAN |
Brand/Generic | Generic |
Proprietary Name | Argatroban |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Argatroban |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 250 |
Active Ingredient Units | mg/2.5mL |
Substance Name | ARGATROBAN |
Labeler Name | Par Pharmaceutical, Inc. |
Pharmaceutical Class | Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA091665 |
Listing Certified Through | 2024-12-31 |
Package
NDC 42023-0182-01 (42023018201)
NDC Package Code | 42023-182-01 |
---|---|
Billing NDC | 42023018201 |
Package | 1 VIAL in 1 CARTON (42023-182-01) / 2.5 mL in 1 VIAL |
Marketing Start Date | 2015-06-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |